Association of gastric cancer with cytochrome P450 2C19 single-nucleotidepolymorphisms in Koreans > Volume 07 - 2007

본문 바로가기

사이트 내 전체검색


 » New Articles(2011~Present)
 » Articles (2001~2010)
      ∙ Volume 10 - 2010
      ∙ Volume 09 - 2009
      ∙ Volume 08 - 2008
      ∙ Volume 07 - 2007
      ∙ Volume 06 - 2006
      ∙ Volume 05 - 2005
      ∙ Volume 04 - 2004
      ∙ Volume 03 - 2003
      ∙ Volume 02 - 2002
      ∙ Volume 01 - 2001
 

Oriental Pharmacy and Experimental Medicine
Volume 07 - 2007
Date: 2007

Journal: Pages 357-362

December 2007 | Association of gastric cancer with cytochrome P450 2C19 single-nucleotidepolymorphisms in Koreans…

Hyun-Ju Kim1, Hye-Jung Park1, Sang-Gyu Lee2, Hye-Suk Lee1, Won-Cheol Park 3, Jeong-Joong Kim3,Gyung-Jae Oh3 and Yun-Kyung Kim1,*

첨부파일

Summary

​Cytochrome P450 2C19 (CYP2C19) is a clinically important enzyme involved in the metabolism oftherapeutic drugs, including (S)-mephenytoin, omeprazole, proguanil, and diazepam. Individuals arecharacterized as either extensive metabolizers (EM) or poor metabolizers (PM) on the basis ofCYP2C19 enzyme activity. The PM phenotype occurs in 2 - 5% of Caucasians, but in 18 - 23% ofAsians. To clarify the association between CYP2C19 polymorphisms and gastric cancer inKoreans, we investigated CYP2C19 genotypes (CYP2C19*1, *2, and *3) in 109 patients with gastriccancer and 211 controls. Normal (CYP2C19*1) and defective alleles were detected withpolymerase chain reaction/restriction enzyme analysis. CYP2C19 has three hereditary genotypes:homozygous EM, with high enzymatic activity; heterozygous EM, with moderate enzymaticactivity; and PM, with no enzyme activity. We found that CYP2C19 heterozygous EM is moreclosely associated with gastric cancer than is homozygous EM. Because the CYP2C19 genotypevaries in Koreans, a genotyping test is desirable to prevent gastropathy recurrence in patientsbefore their doses of omeprazole are reduced during maintenance therapy.


This website Copyright (c) 2014 Institute of Korean Medicine Kyung Hee University All rights reserved.
Top View
Mobile View